Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy Loeb

Showing results (481-490 of 500) with videos related to

Pageof 50
Sort By:
JCO Precision Oncology|March 7, 2024
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline TestingStacy Loeb, Scott W Keith, Heather H Cheng, et al.
Contemporary Clinical Trials|June 16, 2022
Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testingStacy Loeb, Heather H Cheng, Amy Leader, et al.
The Journal of Urology|September 10, 2021
Reply by AuthorsLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
The Journal of Urology|September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional CohortLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
JCO Oncology Practice|May 2, 2025
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate CancerSigrid V Carlsson, Pedro C Barata, Alan H Bryce, et al.
JCO Precision Oncology|September 19, 2025
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS RegistryStacy Loeb, Scott W Keith, Laura Gross, et al.
The Journal of Sexual Medicine|October 3, 2022
Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International PanelDaniela Wittmann, Akanksha Mehta, Eilis McCaughan, et al.
Lancet (London, England)|April 7, 2024
The Lancet Commission on prostate cancer: planning for the surge in casesNicholas D James, Ian Tannock, James N'Dow, et al.
JAMA Oncology|November 20, 2025
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active SurveillanceMatthew R Cooperberg, John R Bihn, John M Culnan, et al.
BMC Public Health|September 17, 2024
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testingAmy E Leader, Timothy R Rebbeck, William K Oh, et al.
Pageof 50

Showing results (481-490 of 500) with videos related to

Sort By:
Pageof 50
JCO Precision Oncology|March 7, 2024
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline TestingStacy Loeb, Scott W Keith, Heather H Cheng, et al.
Contemporary Clinical Trials|June 16, 2022
Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testingStacy Loeb, Heather H Cheng, Amy Leader, et al.
The Journal of Urology|September 10, 2021
Reply by AuthorsLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
The Journal of Urology|September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional CohortLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
JCO Oncology Practice|May 2, 2025
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate CancerSigrid V Carlsson, Pedro C Barata, Alan H Bryce, et al.
JCO Precision Oncology|September 19, 2025
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS RegistryStacy Loeb, Scott W Keith, Laura Gross, et al.
The Journal of Sexual Medicine|October 3, 2022
Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International PanelDaniela Wittmann, Akanksha Mehta, Eilis McCaughan, et al.
Lancet (London, England)|April 7, 2024
The Lancet Commission on prostate cancer: planning for the surge in casesNicholas D James, Ian Tannock, James N'Dow, et al.
JAMA Oncology|November 20, 2025
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active SurveillanceMatthew R Cooperberg, John R Bihn, John M Culnan, et al.
BMC Public Health|September 17, 2024
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testingAmy E Leader, Timothy R Rebbeck, William K Oh, et al.
Pageof 50